FDA Adverse Event Injury Summary report: N

VITALITY 2

MDR report key: 2780547 · Received October 10, 2012

Report

Report Number
2124215-2012-13049
Event Type
Injury
Date Received
October 10, 2012
Date of Event
September 13, 2012
Report Date
September 13, 2012
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXPERIENCED A VENTRICULAR FIBRILLATION (VF) EPISODE THAT RESULTED IN SYNCOPE. THE EPISODE SELF TERMINATED BUT SOME UNDERSENSING WAS NOTED. THE PHYSICIAN DISCUSSED PROGRAMMING THE DEVICE TO BE MORE SENSITIVE. THE PHYSICIAN PLANS TO PERFORM A NON-INVASIVE PROGRAMMED STIMULATION (NIPS) STUDY. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PHYSICIAN REPROGRAMMED THE DEVICE TO A MOST SENSITIVE SETTING AND CHANGED THE PATIENT'S MEDICATION. AFTER THESE CHANGES, A DEFIBRILLATION THRESHOLD (DFT) TEST SUCCESSFULLY DETECTED AND CONVERTED THE PATIENT'S VF.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T175

Patients

Seq Age Sex Outcome Treatment
1 74 YR Hospitalization| L| R 1850| T175| 0148